phenytoin has been researched along with dobutamine in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (20.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Lips, U | 1 |
Alba, D; Garcia, B; Sosa, P; Torres, E | 1 |
Biçer, S; Ctak, A; Karaböcüoğlu, M; Soysal, DD; Uçsel, R; Uzel, N | 1 |
1 review(s) available for phenytoin and dobutamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for phenytoin and dobutamine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
[Drug therapy in eclampsia].
Topics: Blood Pressure; Cerebrovascular Circulation; Cesarean Section; Dexamethasone; Dihydralazine; Dobutamine; Dopamine; Eclampsia; Electrolytes; Female; Heart; Humans; Intracranial Pressure; Nitroglycerin; Phenytoin; Pregnancy; Seizures; Serum Albumin; Thiopental | 1985 |
Cardiovascular complications of TCA overdose.
Topics: Antidepressive Agents, Tricyclic; Bretylium Tosylate; Cardiovascular Diseases; Dobutamine; Humans; Phenytoin | 1984 |
No interaction between dopamine and phenytoin.
Topics: Anti-Arrhythmia Agents; Cardiotonic Agents; Dobutamine; Dopamine; Drug Interactions; Drug Therapy, Combination; Humans; Male; Middle Aged; Phenytoin; Shock, Cardiogenic | 1995 |
Acute colchicine intoxication in a child: a case report.
Topics: Acute Disease; Alopecia; Ataxia; Blood Transfusion; Case Management; Child, Preschool; Colchicine; Combined Modality Therapy; Disseminated Intravascular Coagulation; Dobutamine; Female; Fluid Therapy; Furosemide; Gastroenteritis; Humans; Hyponatremia; Hypotension; Multiple Organ Failure; Pancytopenia; Phenytoin; Poisoning; Seizures | 2007 |